Complementarity and integration of animal and in vitro non-animal pre-clinical model systems- an Australian perspective.
| Τίτλος: | Complementarity and integration of animal and in vitro non-animal pre-clinical model systems- an Australian perspective. |
|---|---|
| Συγγραφείς: | Arkell RM; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Wolvetang EJ; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland,, St Lucia, QLD, Australia., Gulati T; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Hennessy JE; Phenomics Australia, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Hill AP; Victor Chang Cardiac Research Institute, Sydney, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Jardé T; Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, 3800, Australia.; Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3800, Australia., Kueh AJ; Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, Melbourne, VIC, Australia., Thomas PQ; School of Biomedicine, University of Adelaide, Adelaide, South Australia, 5005, Australia.; Genome Editing Program, South Australian Health and Medical Research Institute, Adelaide, South Australia, 5000, Australia., Winteringham LN; Harry Perkins Institute of Medical Research, and Centre for Medical Research, The University of Western Australia, Perth, WA, Australia., Dobbie MS; Phenomics Australia, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia. michael.dobbie@anu.edu.au. |
| Πηγή: | Mammalian genome : official journal of the International Mammalian Genome Society [Mamm Genome] 2025 Jun; Vol. 36 (2), pp. 482-487. Date of Electronic Publication: 2025 May 06. |
| Τύπος έκδοσης: | Letter; Research Support, Non-U.S. Gov't |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Springer-Verlag Country of Publication: United States NLM ID: 9100916 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1777 (Electronic) Linking ISSN: 09388990 NLM ISO Abbreviation: Mamm Genome Subsets: MEDLINE |
| Imprint Name(s): | Publication: New York, NY : Springer-Verlag Original Publication: New York, NY, USA : Springer International, c1991- |
| Ιατρικοί όροι (MeSH): | Models, Animal*, Animals ; Humans ; Australia ; Disease Models, Animal ; Organoids |
| Περίληψη: | Recent advances in the development of pre-clinical models based on non-animal technologies (NATs) have stimulated expectations that the use of animals in research may soon be phased out. The true value of innovations in NATs and their applications lies, however, in enabling an expanded and integrated portfolio of complementary animal and non-animal model systems to improve the accuracy and efficiency of pre-clinical research and therapeutic development. The term NATs covers a range of techniques spanning in silico, cell free, organ-on-chip as well as in vitro techniques including three-dimensional cell culture models termed organoids. Of these, in vitro systems are currently the most broadly used in biomedicine laboratories and are the first NATs for which Australia has invested in nationwide support. The focus of this commentary is the importance of understanding the strengths and limitations of in vitro and animal models such that an integrated portfolio of complementary genetic models continues to evolve to best support pre-clinical research and therapeutic development pipelines. (© 2025. The Author(s).) |
| Competing Interests: | Declarations. Competing interests: The authors declare no competing interests. |
| References: | Ann Med. 2022 Dec;54(1):2581-2597. (PMID: 36194178) Sci Transl Med. 2019 Oct 9;11(513):. (PMID: 31597751) Nat Rev Mol Cell Biol. 2020 Oct;21(10):571-584. (PMID: 32636524) Biofabrication. 2024 May 15;16(3):. (PMID: 38697093) Gastroenterol Rep (Oxf). 2018 Nov;6(4):243-245. (PMID: 30430011) Nat Commun. 2023 Apr 18;14(1):2214. (PMID: 37072390) Artif Organs. 2023 Mar;47(3):449-450. (PMID: 36762462) |
| Contributed Indexing: | Keywords: Non-animal technologies; Organoids; Pre-clinical models |
| Entry Date(s): | Date Created: 20250506 Date Completed: 20250603 Latest Revision: 20260507 |
| Update Code: | 20260507 |
| PubMed Central ID: | PMC12130077 |
| DOI: | 10.1007/s00335-025-10132-0 |
| PMID: | 40329001 |
| Βάση Δεδομένων: | MEDLINE |
| FullText | Links: – Type: other Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=4C6D817C93AE4AC27F98&Show=Object Text: Availability: 0 CustomLinks: – Url: https://dx.doi.org/doi:10.1007/s00335-025-10132-0 Name: EDS - Springer Nature Journals (s7799221) Category: fullText Text: View record at Springer |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 40329001 AccessLevel: 3 PubType: Report PubTypeId: report PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Complementarity and integration of animal and in vitro non-animal pre-clinical model systems- an Australian perspective. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Arkell+RM%22">Arkell RM</searchLink>; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Wolvetang+EJ%22">Wolvetang EJ</searchLink>; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland,, St Lucia, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Gulati+T%22">Gulati T</searchLink>; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Hennessy+JE%22">Hennessy JE</searchLink>; Phenomics Australia, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.<br /><searchLink fieldCode="AU" term="%22Hill+AP%22">Hill AP</searchLink>; Victor Chang Cardiac Research Institute, Sydney, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Jardé+T%22">Jardé T</searchLink>; Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, 3800, Australia.; Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3800, Australia.<br /><searchLink fieldCode="AU" term="%22Kueh+AJ%22">Kueh AJ</searchLink>; Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Thomas+PQ%22">Thomas PQ</searchLink>; School of Biomedicine, University of Adelaide, Adelaide, South Australia, 5005, Australia.; Genome Editing Program, South Australian Health and Medical Research Institute, Adelaide, South Australia, 5000, Australia.<br /><searchLink fieldCode="AU" term="%22Winteringham+LN%22">Winteringham LN</searchLink>; Harry Perkins Institute of Medical Research, and Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Dobbie+MS%22">Dobbie MS</searchLink>; Phenomics Australia, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia. michael.dobbie@anu.edu.au. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229100916%22">Mammalian genome : official journal of the International Mammalian Genome Society</searchLink> [Mamm Genome] 2025 Jun; Vol. 36 (2), pp. 482-487. <i>Date of Electronic Publication: </i>2025 May 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Research Support, Non-U.S. Gov't – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9100916 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1777 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209388990%22">09388990 </searchLink><i>NLM ISO Abbreviation: </i>Mamm Genome <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Publication</i>: New York, NY : Springer-Verlag<br /><i>Original Publication</i>: New York, NY, USA : Springer International, c1991- – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Models%2C+Animal%22">Models, Animal*</searchLink><br /><searchLink fieldCode="MH" term="%22Animals%22">Animals</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Australia%22">Australia</searchLink> ; <searchLink fieldCode="MH" term="%22Disease+Models%2C+Animal%22">Disease Models, Animal</searchLink> ; <searchLink fieldCode="MH" term="%22Organoids%22">Organoids</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Recent advances in the development of pre-clinical models based on non-animal technologies (NATs) have stimulated expectations that the use of animals in research may soon be phased out. The true value of innovations in NATs and their applications lies, however, in enabling an expanded and integrated portfolio of complementary animal and non-animal model systems to improve the accuracy and efficiency of pre-clinical research and therapeutic development. The term NATs covers a range of techniques spanning in silico, cell free, organ-on-chip as well as in vitro techniques including three-dimensional cell culture models termed organoids. Of these, in vitro systems are currently the most broadly used in biomedicine laboratories and are the first NATs for which Australia has invested in nationwide support. The focus of this commentary is the importance of understanding the strengths and limitations of in vitro and animal models such that an integrated portfolio of complementary genetic models continues to evolve to best support pre-clinical research and therapeutic development pipelines.<br /> (© 2025. The Author(s).) – Name: Abstract Label: Competing Interests Group: Ab Data: Declarations. Competing interests: The authors declare no competing interests. – Name: Ref Label: References Group: RefInfo Data: Ann Med. 2022 Dec;54(1):2581-2597. (PMID: <searchLink fieldCode="PM" term="%2236194178%22">36194178)</searchLink><br />Sci Transl Med. 2019 Oct 9;11(513):. (PMID: <searchLink fieldCode="PM" term="%2231597751%22">31597751)</searchLink><br />Nat Rev Mol Cell Biol. 2020 Oct;21(10):571-584. (PMID: <searchLink fieldCode="PM" term="%2232636524%22">32636524)</searchLink><br />Biofabrication. 2024 May 15;16(3):. (PMID: <searchLink fieldCode="PM" term="%2238697093%22">38697093)</searchLink><br />Gastroenterol Rep (Oxf). 2018 Nov;6(4):243-245. (PMID: <searchLink fieldCode="PM" term="%2230430011%22">30430011)</searchLink><br />Nat Commun. 2023 Apr 18;14(1):2214. (PMID: <searchLink fieldCode="PM" term="%2237072390%22">37072390)</searchLink><br />Artif Organs. 2023 Mar;47(3):449-450. (PMID: <searchLink fieldCode="PM" term="%2236762462%22">36762462)</searchLink> – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>Non-animal technologies; Organoids; Pre-clinical models – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20250506 <i>Date Completed: </i>20250603 <i>Latest Revision: </i>20260507 – Name: DateUpdate Label: Update Code Group: Date Data: 20260507 – Name: PubmedCentralID Label: PubMed Central ID Group: ID Data: PMC12130077 – Name: DOI Label: DOI Group: ID Data: 10.1007/s00335-025-10132-0 – Name: AN Label: PMID Group: ID Data: 40329001 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=40329001 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00335-025-10132-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 482 Subjects: – SubjectFull: Animals Type: general – SubjectFull: Humans Type: general – SubjectFull: Australia Type: general – SubjectFull: Disease Models, Animal Type: general – SubjectFull: Organoids Type: general – SubjectFull: Models, Animal Type: general Titles: – TitleFull: Complementarity and integration of animal and in vitro non-animal pre-clinical model systems- an Australian perspective. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Arkell RM – PersonEntity: Name: NameFull: Wolvetang EJ – PersonEntity: Name: NameFull: Gulati T – PersonEntity: Name: NameFull: Hennessy JE – PersonEntity: Name: NameFull: Hill AP – PersonEntity: Name: NameFull: Jardé T – PersonEntity: Name: NameFull: Kueh AJ – PersonEntity: Name: NameFull: Thomas PQ – PersonEntity: Name: NameFull: Winteringham LN – PersonEntity: Name: NameFull: Dobbie MS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2025 Jun Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1432-1777 Numbering: – Type: volume Value: 36 – Type: issue Value: 2 Titles: – TitleFull: Mammalian genome : official journal of the International Mammalian Genome Society Type: main |
| ResultId | 1 |